Table of Contents Author Guidelines Submit a Manuscript
Journal of Nutrition and Metabolism
Volume 2016, Article ID 2453027, 5 pages
http://dx.doi.org/10.1155/2016/2453027
Research Article

The Use of Glycomacropeptide in Dietary Management of Phenylketonuria

1Genetics Unit, Pediatrics Hospital, Ain Shams University, Ramsis Street, Abbasia, Cairo 11566, Egypt
2College of Pharmacy, Ain Shams University, Abbasia, Cairo, Egypt

Received 1 January 2016; Revised 20 April 2016; Accepted 24 April 2016

Academic Editor: Michael B. Zemel

Copyright © 2016 Osama K. Zaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. M. Camp, M. A. Parisi, P. B. Acosta et al., “Phenylketonuria Scientific Review Conference: state of the science and future research needs,” Molecular Genetics and Metabolism, vol. 112, no. 2, pp. 87–122, 2014. View at Publisher · View at Google Scholar
  2. J. Vockley, H. C. Andersson, K. M. Antshel et al., “Phenylalanine hydroxylase deficiency: diagnosis and management guideline,” Genetics in Medicine, vol. 16, no. 2, pp. 188–200, 2013. View at Google Scholar
  3. G. Hoffmann, P. Burgard, and J. Pietz, “Störungen im Stoffwechsel von Amino- und Karbonsäuren,” in Stoffwechselerkrankungen der Neurologie, pp. 109–130, Thieme, 2004. View at Google Scholar
  4. A. MacDonald, “Diet and compliance in phenylketonuria,” European Journal of Pediatrics, vol. 159, no. 2, pp. S136–S141, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. A. MacDonald, A. Daly, P. Davies et al., “Protein substitutes for PKU: what's new?” Journal of Inherited Metabolic Disease, vol. 27, no. 3, pp. 363–371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Marshall, “Therapeutic applications of whey protein,” Alternative Medicine Review, vol. 9, no. 2, pp. 136–156, 2004. View at Google Scholar · View at Scopus
  7. D. M. Ney, A. K. Hull, S. C. van Calcar, X. Liu, and M. R. Etzel, “Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria,” Journal of Nutrition, vol. 138, no. 2, pp. 316–322, 2008. View at Google Scholar · View at Scopus
  8. G. W. Krissansen, “Emerging health properties of whey proteins and their clinical implications,” Journal of the American College of Nutrition, vol. 26, no. 6, pp. 713S–723S, 2007. View at Google Scholar · View at Scopus
  9. P. Solverson, S. G. Murali, A. S. Brinkman et al., “Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria,” American Journal of Physiology—Endocrinology and Metabolism, vol. 302, no. 7, pp. E885–E895, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Solverson, S. G. Murali, S. J. Litscher, R. D. Blank, and D. M. Ney, “Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet,” PLoS ONE, vol. 7, no. 9, Article ID e45165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. C. Van Calcar, E. L. MacLeod, S. T. Gleason et al., “Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids,” The American Journal of Clinical Nutrition, vol. 89, no. 4, pp. 1068–1077, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Ney, S. T. Gleason, S. C. van Calcar et al., “Nutritional management of PKU with glycomacropeptide from cheese whey,” Journal of Inherited Metabolic Disease, vol. 32, no. 1, pp. 32–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. V. R. Young and S. Borgonha, “Nitrogen and amino acid requirements: the Massachusetts Institute of Technology amino acid requirement pattern,” The Journal of Nutrition, vol. 130, no. 7, pp. 1841S–1849S, 2000. View at Google Scholar · View at Scopus
  14. D. M. Ney, H. L. L. Bridget, M. Stroup Murray, K. Clayton Sangita, G. Murali Gregory, M. Rice Frances Rohr et al., “Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled crossover trial,” Molecular Genetics and Metabolism, vol. 117, no. 3, abstract 81, p. 274, 2016. View at Google Scholar
  15. A. Daly, A. MacDonald, S. Evans, and S. Chahal, “Glycomacropeptide: can we safely advocate its use in children with PKU?” Journal of Inherited Metabolic Disease, vol. 38, pp. S35–S39, 2015. View at Google Scholar
  16. E. L. MacLeod, M. K. Clayton, S. C. van Calcar, and D. M. Ney, “Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria,” Molecular Genetics and Metabolism, vol. 100, no. 4, pp. 303–308, 2010. View at Publisher · View at Google Scholar · View at Scopus